New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology – TechCrunch
Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North...
